Neuro-muscular innervation in neonatal intestinal development
Neuro-muscular innervation in neonatal intestinal development
批准号:
RGPIN-2015-05614
负责人:
Blennerhassett, Michael
金额:
$2.48万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-01-01 至 2020-12-31
中文摘要
我们来看看新生哺乳动物肠道神经肌肉层的发育,在达到成年大小之前,它会延长许多倍。这涉及平滑肌细胞的广泛生长以产生成人形式。然而,肠神经系统(ENS)的神经元在出生时就存在,必须与此协调,并发展成成人的神经支配模式,因为ENS最终将调节平滑肌的及时收缩和舒张,使其能够正常消化。我们的目标是了解出生时的神经元如何保持活力并适应其靶细胞的快速生长,从而创造出成年人中所见的复杂,稳定的关系。目前的支持表明,一个单一的因素(GDNF;神经营养因子)是负责ENS神经元的生存出生后,GDNF是由肠平滑肌细胞。关键的是,这些细胞的生长是GDNF表达增加所必需的,GDNF表达增加导致神经元存活和轴突生长。我们认为GDNF与其受体RET的结合导致两种结果:最初是存活,然后是轴突延伸,并且可能每种结果都需要不同水平的GDNF。我们拥有解决这一问题所需的细胞和分子技术,以及涉及新生肠神经元和平滑肌细胞的独特组织培养模型。我们将用阻断神经元(唯一表达GDNF受体的细胞)中不同通路的药理学抑制剂分离GDNF信号传导的结果,然后测量存活的细胞结果或轴突生长的程度。然后,我们将研究神经元生长完成时对GDNF的需求-非常低的水平是否可以维持生存?这个信号是如何实现的?*成年人的肠似乎没有轴突生长,但当它出现以促进修复时,神经元功能不佳,这在其他神经损伤中也可见。我们现在认为新生ENS的轴突生长和神经功能(即动作电位和神经递质释放)往往不会同时发生。因此,随着功能性程序获得优势,神经递质的合成、储存和释放,结构程序变得完整。定量测量所涉及的步骤,如mRNA和蛋白质,将测量属于这些程序之一的关键蛋白质,这将与神经元显示成熟信号特性的能力相关。这将有助于我们了解新生儿的肠道是如何发育的,这是一个知之甚少的领域。我将与实习生一起工作,他们主要是研究生和高年级的本科生。他们将获得技术专业知识以及科学思维和批判性评价方面的教育。迄今为止,我们的毕业生非常成功,在这一领域的重要出版物,以及非常好的职业成就。
英文摘要
We look at the development of the neuromuscular layer of the newborn mammalian intestine, which will lengthen many-fold before reaching its adult size. This involves extensive growth of the smooth muscle cells to create the adult form. However, the neurons of the enteric nervous system (ENS), which are all present at birth, must coordinate with this and develop the adult pattern of innervation, as the ENS will eventually regulate the timely contraction and relaxation of the smooth muscle that allows normal digestion. Our goal is to understand how neurons at birth stay alive and adapt to the rapid growth of their target cells, creating the complex, stable relationship seen in the adult.****Current support showed us that a single factor (GDNF; a neurotrophin) is responsible for survival of the ENS neurons after birth, and that GDNF is made by the intestinal smooth muscle cells. Critically, growth of these cells is required for increased GDNF expression that leads to neuron survival and axon outgrowth. We propose that the binding of GDNF to its receptor, RET, causes two outcomes: initially, survival and then axonal extension, and it may be that different levels of GDNF are required for each. We have the cellular and molecular techniques needed to address this, and a unique tissue culture model involving both neonatal intestinal neurons and smooth muscle cells. We will separate the outcomes of GDNF signalling with pharmacological inhibitors that block distinct pathways in the neurons (the only cells expressing GDNF receptors) , and then measure cellular outcomes of survival or the degree of axonal outgrowth. We will then examine the requirements of neurons for GDNF when growth is complete - do very low levels maintain survival? How is this signalling achieved?****Axonal outgrowth seems absent in the adult intestine, but when it arises to facilitate repair, the neurons do not function well, and this is seen elsewhere with nerve damage. We now think that axon outgrowth and nerve function in the neonatal ENS (ie, action potentials and neurotransmitter release) tend not to occur at the same time. Therefore, the structural programme becomes complete as the functional programme gains ascendancy, with synthesis, storage and release of neurotransmitters. Quantitative measurement of the steps involved, such as mRNA and protein, will measure key proteins that belong in either one of these programmes, and this will be correlated with the ability of the neurons to display mature signalling properties. This will help us to understand how the intestine develops in the neonate, a field where little is known.****I will work with trainees, who will mainly be graduate students as well as senior undergraduates. They will gain both technical expertise as well as education in scientific thinking and critical evaluation. To date, our graduates are highly successful, with significant publications in this field, and very good career achievements.**********
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuro-muscular innervation in neonatal intestinal development
-
批准号:RGPIN-2015-05614
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.48万
-
财政年份:2021
-
负责人:Blennerhassett, Michael
-
依托单位:
Neuro-muscular innervation in neonatal intestinal development
-
批准号:RGPIN-2015-05614
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.48万
-
财政年份:2020
-
负责人:Blennerhassett, Michael
-
依托单位:
Neuro-muscular innervation in neonatal intestinal development
-
批准号:RGPIN-2015-05614
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.48万
-
财政年份:2018
-
负责人:Blennerhassett, Michael
-
依托单位:
Neuro-muscular innervation in neonatal intestinal development
-
批准号:RGPIN-2015-05614
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.48万
-
财政年份:2017
-
负责人:Blennerhassett, Michael
-
依托单位:
Neuro-muscular innervation in neonatal intestinal development
-
批准号:RGPIN-2015-05614
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.48万
-
财政年份:2016
-
负责人:Blennerhassett, Michael
-
依托单位:
GDNF and development of the intestinal nervous system
-
批准号:312246-2010
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.83万
-
财政年份:2014
-
负责人:Blennerhassett, Michael
-
依托单位:
GDNF and development of the intestinal nervous system
-
批准号:312246-2010
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.83万
-
财政年份:2013
-
负责人:Blennerhassett, Michael
-
依托单位:
GDNF and development of the intestinal nervous system
-
批准号:312246-2010
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.83万
-
财政年份:2012
-
负责人:Blennerhassett, Michael
-
依托单位:
GDNF and development of the intestinal nervous system
-
批准号:312246-2010
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.83万
-
财政年份:2011
-
负责人:Blennerhassett, Michael
-
依托单位:
GDNF and development of the intestinal nervous system
-
批准号:312246-2010
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.83万
-
财政年份:2010
-
负责人:Blennerhassett, Michael
-
依托单位:
NGF receptor system in the adult intestine
-
批准号:312246-2005
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.11万
-
财政年份:2009
-
负责人:Blennerhassett, Michael
-
依托单位:
NGF receptor system in the adult intestine
-
批准号:312246-2005
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.11万
-
财政年份:2008
-
负责人:Blennerhassett, Michael
-
依托单位:
NGF receptor system in the adult intestine
-
批准号:312246-2005
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.11万
-
财政年份:2007
-
负责人:Blennerhassett, Michael
-
依托单位:
NGF receptor system in the adult intestine
-
批准号:312246-2005
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.11万
-
财政年份:2006
-
负责人:Blennerhassett, Michael
-
依托单位:
NGF receptor system in the adult intestine
-
批准号:312246-2005
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.11万
-
财政年份:2005
-
负责人:Blennerhassett, Michael
-
依托单位:
国内基金
海外基金
新型靶向肽的筛选及在杜兴肌肉萎缩症动物模型上的应用研究
-
批准号:81101340
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:王青松
-
依托单位:
新型寡核苷酸药物在杜兴肌肉萎缩症基因治疗上的应用研究
-
批准号:81071443
-
项目类别:面上项目
-
资助金额:37.0万元
-
批准年份:2010
-
负责人:尹海芳
-
依托单位: